Patients are less likely to receive lipid-lowering drugs

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.371, 2002-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New prospects for lipid-lowering drugs

By Thompson G.R. Naoumova R.P.

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. : 715-727

Informa Healthcare

Access to resources Recommend Favorite

Despite guidelines recommending intensive lipid-lowering therapy in patients with ACS, most such patients do not receive such treatment

Inpharma, Vol. 1, Iss. 1613, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Despite guidelines recommending intensive lipid-lowering therapy in patients with ACS, most such patients do not receive such treatment

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 541, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Black patients less likely to receive reperfusion therapy for MI

Inpharma, Vol. 1, Iss. 1234, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Emerging lipid-lowering drugs: squalene synthase inhibitors

By Elsayed Raghda K Evans Jeffery D

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 309-322

Informa Healthcare

Access to resources Recommend Favorite